J. Biton

发表

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

N. Bercovici, M. Alifano, D. Damotte, 2018, Proceedings of the National Academy of Sciences.

Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer

N. Roche, I. Cremer, M. Alifano, 2014, PloS one.

Reply: To PMID 24504799.

C. Jorgensen, Y. Pers, J. Biton, 2014, Arthritis & rheumatology.

C. Jorgensen, Y. Pers, J. Biton, 2014 .

SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils.

L. Fournel, F. Petitprez, I. Cremer, 2022, Lung cancer.

Air pollution as a determinant of rheumatoid arthritis.

J. Biton, M. Boissier, L. Semerano, 2019, Joint, bone, spine : revue du rhumatisme.

TNFα: activator or inhibitor of regulatory T cells?

J. Biton, N. Bessis, M. Boissier, 2012, Joint, bone, spine : revue du rhumatisme.

Response to Comment on “Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis”

J. Biton, N. Bessis, M. Boissier, 2011, The Journal of Immunology.

Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment

A. Herbelin, J. Biton, E. Bourgeois, 2010, Immunology.

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis

A. Herbelin, J. Girard, J. Biton, 2016, The Journal of Immunology.

Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis

J. Biton, N. Bessis, M. Boissier, 2011, The Journal of Immunology.

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33

A. Herbelin, J. Girard, J. Biton, 2016, Arthritis Research & Therapy.

Interleukin‐6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

C. Jorgensen, Y. Pers, J. Biton, 2014, Arthritis & rheumatology.

Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels

J. Biton, E. Assier, O. Dhellin, 2013, Clinical and experimental immunology.

Regulatory T cells (Treg) in rheumatoid arthritis.

Eric Assier, Marie-Christophe Boissier, Géraldine Falgarone, 2009, Joint, bone, spine : revue du rhumatisme.

Impaired Tumor‐Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD‐1 Blockade

T. Creasy, L. Fournel, N. Roche, 2018, American journal of respiratory and critical care medicine.

TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

P. Laurent-Puig, I. Cremer, K. Leroy, 2018, Clinical Cancer Research.

Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations.

P. Laurent-Puig, I. Cremer, E. Becht, 2016, American journal of respiratory and critical care medicine.

Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients

N. Girard, D. Gossot, P. Validire, 2021, Frontiers in Immunology.

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis.

G. Kroemer, C. Sautès-Fridman, W. Fridman, 2016, Cancer research.

Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice.

D. Lutomski, M. Petit, J. Biton, 2014, Cytokine.

Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients

I. Cremer, M. Alifano, D. Damotte, 2016, Oncoimmunology.

A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis

W. B. van den Berg, F. V. D. van de Loo, S. Veenbergen, 2011, Annals of the rheumatic diseases.

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

N. Girard, D. Gossot, P. Validire, 2018, Oncoimmunology.

Origins of rheumatoid arthritis.

J. Biton, P. Decker, N. Bessis, 2019, Joint, bone, spine : revue du rhumatisme.

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

T. Creasy, S. Warren, K. Leroy, 2019, Journal of Translational Medicine.

Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors

L. Fournel, P. Laurent-Puig, I. Cremer, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The exposome in rheumatoid arthritis.

J. Biton, N. Saidenberg-Kermanac’h, P. Decker, 2022, Joint bone spine.

The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.

P. Laurent-Puig, C. Sautès-Fridman, I. Cremer, 2014, Chest.

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

T. Creasy, K. Leroy, F. Goldwasser, 2019, Journal of Translational Medicine.

Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

M. Ziol, J. Tost, F. Busato, 2020, Arthritis & Rheumatology.

TNFR2 associates with FoxP3 stability and identifies asubset of regulatory T cells that are specifically expanded by anti-TNF treatments in rheumatoid arthritis.

M. Ziol, J. Tost, F. Busato, 2019, Arthritis & rheumatology.

Interleukin‐6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

Y. Pers, J. Biton, A. Thiolat, 2014, Arthritis & rheumatology.